Inactive Instrument

Brighter AB (publ)

BRIG

SE0004019545

Advanced Medical Equipment & Technology

Brighter AB Provides Revenue Guidance for the Year 2021

May 21, 2021 at 09:45 am

Brighter AB (publ) provided revenue guidance for the year 2021. The company continues to be poised for revenue momentum at the end of the year.

Latest news about Brighter AB (publ)

Brighter Files for Bankruptcy After Court Orders End to Corporate Restructuring	23/11/22	MT
Brighter Postpones Publication of Third Quarter Report	23/11/22	CI
Nasdaq Stockholm Fines Brighter For Violating Listing Rules On Insider Information	23/11/22	MT
Brighter Dips Over 55% as Court Orders End to Corporate Restructuring	21/11/22	MT
Brighter Surges 181% As It Enters Corporate Restructuring	02/11/22	MT
Brighter Shares Plunge 63% on Corporate Restructuring Plan	01/11/22	MT
Brighter AB Applies for Corporate Restructuring in Bid for Longer-Term Financing	01/11/22	CI
Brighter Falls 17% as Stockholm Court OKs Nectarine Health's Bankruptcy Application	17/10/22	MT
Brighter Unit Receives Regulatory Approval for Corporate Restructuring	30/09/22	MT
Swedish Regulator Investigates Brighter's Former Chairman, CEO	26/09/22	MT
Brighter Unit Applies for Corporate Restructuring	23/09/22	MT
Brighter Subsidiary Faces Repayment Demand From Swedish Tax Agency	15/09/22	MT
Brighter Boosts Loan Financing Deal With Formue Nord Markedsneutral	13/09/22	MT
Brighter AB Expands Loan Financing with Formue Nord Markedsneutral of SEK 10.0 Million	13/09/22	CI
Brighter CFO Steps Down; Interim Finance Chief Named	06/09/22	MT
Brighter AB Announces Executive Changes	06/09/22	CI
Brighter Plans $5 Million Rights Issue to Fund Commercialization of Actiste Device; Shares Sink 25%	25/08/22	MT
Brighter AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/08/22	CI
Brighter Receives UAE Regulatory Approval For Actiste Device	02/08/22	MT
Brighter AB (Publ.) Announces its Actiste® Receives Telecommunication Type Approval in the United Arab Emirates	02/08/22	CI
Brighter Receives Regulatory Approval In UAE For Pilot Research on Diabetes Treatment	21/07/22	MT
Brighter AB Receives Final Approvals for Pilot Research with Insulin-Treated Diabetes Patients in the UAE	21/07/22	CI
Brighter Confirms Interim CEO To Permanent Role	30/06/22	MT
Brighter Confirms Interim CEO	30/06/22	MT
Brighter's Interim CEO Erik Lissner Takes Permanent Role as the Company CEO	30/06/22	CI

Brighter AB (publ) is a Sweden-based technology company engaged in the healthcare sector. The Company offers solutions related to diabetes care, welfare technology and digital healthcare services. Brighter AB (publ) is a Parent Company, that operates through group of subsidiaries. The group's main purpose is to improve health and wellbeing amongst the global population through development of technical and digital medical devices with a primary area of application in the treatment of diabetes. The Company reports the following operating segments: Brighter, Camanio and Nectarine Health.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VEEVA SYSTEMS INC.	+5.43%	32.95B
PRO MEDICUS LIMITED	+19.28%	7.87B
SECTRA AB	+33.25%	4.35B
EVOLENT HEALTH, INC.	-30.06%	2.67B
OMNICELL, INC.	-14.90%	1.5B
VERADIGM INC.	-19.92%	1.27B
LUNIT INC.	-35.41%	1.16B
SIMULATIONS PLUS, INC.	+10.34%	996M
B-SOFT CO.,LTD.	-39.85%	859M

Medical Software & Technology Services

Brighter AB (publ)

Equities

BRIG

SE0004019545

Advanced Medical Equipment & Technology

Brighter AB Provides Revenue Guidance for the Year 2021

Latest news about Brighter AB (publ)

Chart Brighter AB (publ)

Company Profile

Sector Medical Software & Technology Services